Natural Biodrugs Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 05-12-2024
- Paid Up Capital ₹ 0.20 M
as on 05-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -16.21%
(FY 2017)
- Profit 32.98%
(FY 2017)
- Ebitda 17.24%
(FY 2017)
- Net Worth 0.77%
(FY 2017)
- Total Assets 8.57%
(FY 2017)
About Natural Biodrugs
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mohit Aggarwal and Renu Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2013PTC042114
- Company No.
042114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Ganganagar, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Natural Biodrugs Private Limited offer?
Natural Biodrugs Private Limited offers a wide range of products and services, including Multivitamin Syrup & Drops, Multivitamin Drops, Ayurvedic Medicine, Ayurvedic Kidney Medicine, Sewerage and Drainage Products, Drainage Pipes & Pipe Fittings, Vitrified,Ceramic Floor & Wall Tiles, Outdoor Tiles, Herbal Piles Medicine, Herbal Piles Capsules and Tablets.
Who are the key members and board of directors at Natural Biodrugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Renu Goyal  | Director | 15-Apr-2013 | Current |
| Mohit Aggarwal | Director | 15-Apr-2013 | Current |
Financial Performance of Natural Biodrugs.
Natural Biodrugs Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 16.21% decrease. The company also saw a substantial improvement in profitability, with a 32.98% increase in profit. The company's net worth moved up by a moderate rise of 0.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natural Biodrugs?
In 2017, Natural Biodrugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natural Biodrugs?
Unlock and access historical data on people associated with Natural Biodrugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natural Biodrugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natural Biodrugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
